AVORA has already built an impressive client base, including Telefonica, OMD, NPR, HBO LatAm and Ocado. The UK start-up will use the funds raised to expand its leadership and sales teams, launch in the US market and continue to evolve its technology by enhancing its in-platform machine learning algorithms.
Egress will use this investment to build on its ongoing rapid growth in Europe and North America, as well as accelerate development of new technology across its data security platform.
The funding will be used to develop Raremark’s patient-engagement and data-analysis technology.
The company’s insulin and glucagon products, which are set to transform diabetes treatments, could have peak annual sales of between $200 million and $1 billion each.
Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies
Hazy offers a unique platform that allows businesses to share data responsibly and securely through a workflow tool, automatically anonymises and adapting to changing datasets.
Quantexa now boasts a workforce of over 90 and engagements with some of the world’s largest organisations
Phrasee is world-leading AI that generates and optimises marketing copy at scale, delivering improved results for email subject lines, push notifications, and Facebook and Instagram ads.